Searched for
INDIA DRUG REGULATOR ADVISORY
Fortis audit order could drag listed firms into promoters' personal debt cases: InGovernInGovern has warned that the Delhi High Court’s Fortis Healthcare forensic audit order could set a wider precedent, potentially exposing li...- Drug regulator warns against prolonged use of painkillers, antibioticsIndia’s drug regulator has warned against the indiscriminate, repeated or prolonged use of painkillers and antibiotics, citing risks includ...
- Medical device rules may get tougher: Govt plans new powers to stop manufacture, sale of unsafe, defective and spurious products, order destructionThe government is considering tougher medical device rules that could give regulators explicit powers to stop the manufacture, sale or dist...
- Before giving cough syrup to your child, check the bottle: Sale still continues despite advisory for kids under 4; check what changes are being plannedIndia's drug regulatory authority is evaluating the introduction of new warning labels for cough syrups. These proposed labels will promine...
- Cockroach found at JW Marriott Mumbai restaurant ruins Fortis cardiologist Dr Ashok Seth’s dinner, but he is thankful he is inside Tukaram Mundhe’s territoryA baby cockroach appeared on Fortis cardiologist Dr Ashok Seth's dinner table at Romano’s, the Italian restaurant at JW Marriott Mumbai Sah...
- ‘We need to balance business & livelihoods with public health,' says Maharashtra FDA chief Tukaram MundheMaharashtra FDA commissioner Tukaram Mundhe says India must improve street-food hygiene without hurting vendors’ livelihoods. He backs desi...
- Drug-free India by 2029: Centre lays out 3-year roadmap with 200-plus actionsIndia aims to become drug-free by 2029 with a detailed three-year roadmap. This plan focuses on enforcement, synthetic drugs, demand reduct...
- Cough syrup bottles may soon carry a warning label in 'red'The move comes amid continued concerns over the prescribing of cough syrups to infants and young children, despite a directorate general of...
- Government to ease BA-BE study norms for domestic generic drug approvals, cut import licence timelinesPharmaceutical companies will soon find it easier to conduct drug studies. Applicants can start eligible trials after intimating the drug r...
- Drugs Panel to weigh bringing all sterile drug products under central licensing amid contamination concernsA proposal will soon be considered to centralize licensing for all sterile drug products. This move aims to tighten regulations on medicine...
- Health ministry issues advisory against unregulated stem cell therapies, restricts autism treatment to approved clinical trialsThe Union health ministry issued an advisory against unregulated stem cell therapies. Therapeutic use of stem cells for autism is restricte...
- Health Ministry proposes CCTV surveillance at medical stores selling prescription drugsIn a bid to enhance regulation, the Union Health Ministry has put forth a proposal for mandatory CCTV installations at pharmacies across In...
- Health Ministry issues advisory clamping down on unregulated use of stem cell therapiesThe Union Health Ministry has tightened oversight of stem cell therapies, warning against their unregulated use and making clear that they ...
- Trump praises PM Modi's opium crackdown as India remains on US drug listUS President Donald Trump praised Prime Minister Narendra Modi for tackling opium production, even as India remains on Washington's major i...
- Supreme Court upholds Himachal HC ruling on drug regulator powers, impacting CDSCO enforcementThe Supreme Court dismissed the Union government's challenge to a High Court judgment. This ruling clarified jurisdiction over drug regulat...
- US names India, China, Pakistan among drug transit, illicit drug-producing nations for FY27The United States has designated India, China, and Pakistan as major drug producing or transit countries. This presidential determination c...
- Agonisingly slow clinical trial is stopping Indian pharma become global innovator from supplierIndia's regulatory hurdles slow down early-stage drug trials significantly. This complexity causes Indian companies to conduct crucial firs...
- Centre proposes easier norms for faster drug rolloutIndia's government plans to streamline drug approval processes for domestic use. Applicants can now start studies after intimating the drug...
- Airlines directed by DGCA to test all pilots following Air India drugs row, report saysThe move follows an unusual incident involving an Air India-operated Airbus SE A320, in which all three hydraulic systems failed. Such a si...
- Government panel plans to retain rule allowing doorstep drug deliveryA government sub-committee has decided to uphold the 2020 rule for doorstep delivery of medicines, recognizing its critical importance for ...
Load More
